As of 2025-05-23, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (13.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -186.6%.
The range of the Relative Valuation is (13.51) - (12.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 17.1x | 17.0x |
| Forward P/E multiples | 18.3x - 20.0x | 18.8x |
| Fair Price | (13.51) - (12.68) | (13.20) |
| Upside | -188.6% - -183.1% | -186.6% |
| Date | P/E |